Anti-inflammatory esters of 4-(1-hydroxy-2-[(acylamino)-alkylami

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Other Related Categories

514448, 514438, 514469, 514471, 549 57, 549 64, 549 65, 549467, 549487, A61K 3134, A61K 3138, C07D30746, C07D30780

Type

Patent

Status

active

Patent number

045686912

Description

ABSTRACT:
The invention concerns novel esters of 4-(1-hydroxy-2-[(acylamino)alkylamino]ethyl)phenols of the formula: ##STR1## and salts thereof, wherein R.sup.1 and R.sup.2 are (3-5C)alkyl, R.sup.3 and R.sup.4 are hydrogen or methyl, A is a direct bond or methylene, and Q is various heteroaromatic containing groups. The esters possess topical anti-inflammatory properties and the invention provides pharmaceutical compositions containing the esters and processes for their chemical manufacture.

REFERENCES:
patent: 3686206 (1972-08-01), Posselt et al.
patent: 4303649 (1981-12-01), Jones
patent: 4323575 (1982-04-01), Jones
patent: 4355045 (1982-10-01), Preston et al.
Jones et al., CA, vol. 89, 1978, 89:129233V, p. 564.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Anti-inflammatory esters of 4-(1-hydroxy-2-[(acylamino)-alkylami does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-inflammatory esters of 4-(1-hydroxy-2-[(acylamino)-alkylami, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-inflammatory esters of 4-(1-hydroxy-2-[(acylamino)-alkylami will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2341191

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.